ARWR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03

Harga $64.19

Kapitalisasi Pasar (MRQ) $9.06B

P/E (TTM) -29.4

EPS (TTM) $-2.18

Pendapatan (TTM) $669M

ROE (TTM) -64.8%

Rentang 52M $35–$95

ARWR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04

rentang

batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Pemecahan saham 2

Tanggal ex-dividen	Pemecahan	Tipe
17 Nov. 2011	1-for-10	Terbalik
15 Jan. 2004	1-for-65	Terbalik

Tentang Arrowhead Pharmaceuticals, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

Wikidata ↗

sektorHealthcare industriBiotechnology karyawan711 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06

Pendapatan$829M

2016-09-30 → 2025-09-30

EPS$-0.01

2017-09-30 → 2025-09-30

Arus Kas Bebas$157M

2016-09-30 → 2025-09-30

Margin bersih-47.8%

2016-09-30 → 2025-09-30

Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik	ARWR	rata-rata 5T	Median Rekan	Kesimpulan
P/E (TTM)	-29.4rata-rata 5T ≈-706.5	≈-706.5	·	·
P/S (TTM)	13.5rata-rata 5T ≈19.8	≈19.8	26.5	Kurang nilai
P/B (MRQ)	19.5rata-rata 5T ≈11.3	≈11.3	8.5	Terlalu mahal
Harga / FCF (TTM)	-120.6rata-rata 5T ≈11.7	≈11.7	·	·
Harga / Arus Kas (TTM)	-153.4rata-rata 5T ≈4.9	≈4.9	63.7	Kurang nilai
Harga / Nilai Buku Berwujud (MRQ)	19.7rata-rata 5T ≈12.1	≈12.1	·	·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik	ARWR	rata-rata 5T	Median Rekan	Kesimpulan
Margin Operasi (TTM)	-33.8%rata-rata 5T ≈-63.6%	≈-63.6%	-53.6%	Lemah
Margin EBITDA (TTM)	-30.2%rata-rata 5T ≈-59.7%	≈-59.7%	-53.6%	Lemah
Margin Sebelum Pajak (TTM)	-37.7%rata-rata 5T ≈-63.1%	≈-63.1%	-0.23%	Lemah
Margin Laba Bersih (TTM)	-47.8%rata-rata 5T ≈-64.9%	≈-64.9%	-47.2%	Lemah
ROA (TTM)	-18.3%rata-rata 5T ≈-19.1%	≈-19.1%	-18.4%	Tingkat teratas
ROE (TTM)	-64.8%rata-rata 5T ≈-35.1%	≈-35.1%	-0.50%	Sejajar
ROIC	12.3%rata-rata 5T ≈-36.6%	≈-36.6%	12.3%	Sejajar

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik	Tren 5 Tahun	ARWR	rata-rata 5T	Median Rekan	Kesimpulan
Rasio Lancar (MRQ)		5.9rata-rata 5T ≈3.6	≈3.6	5.9	Sejajar
Quick Ratio (Rasio Cepat)		0.0rata-rata 5T ≈0.6	≈0.6	3.6	Likuiditas rendah

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik	ARWR	rata-rata 5T	Median Rekan	Kesimpulan
Revenue YoY (Pendapatan YoY)	23258.2%rata-rata 5T ≈4658.3%	≈4658.3%	·	·
Revenue CAGR 3Y (CAGR Pendapatan 3T)	50.5%rata-rata 5T ≈6.6%	≈6.6%	·	·
Revenue CAGR 5Y (CAGR Pendapatan 5T)	56.6%	·	·	·

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik	ARWR	rata-rata 5T	Median Rekan	Kesimpulan
EPS (Diluted)	$-0.01rata-rata 5T ≈$-1.99	≈$-1.99	·	·
Revenue / Share (Pendapatan / Saham)	$6.20rata-rata 5T ≈$3.02	≈$3.02	·	·
Cash Flow / Share (Arus Kas / Saham)	$1.34rata-rata 5T ≈$0.07	≈$0.07	·	·

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik	ARWR	rata-rata 5T	Median Rekan	Kesimpulan
Asset Turnover (Perputaran Aset)	0.7rata-rata 5T ≈0.4	≈0.4	0.3	Tingkat teratas
Receivables Turnover (Perputaran Piutang)	243.1rata-rata 5T ≈162.8	≈162.8	5.1	Tingkat teratas
Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.)	≈$1.2M	·	·	·

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14

Kejutan Rata-rata 245.8%

Periode	Laporan	EPS Aktual	EPS Estimasi	Kejutan
30 Juni 2026	Agu 6, 2026	$-1.36	$-1.35	-1.0%
31 Maret 2026		$-0.93	$-1.21	23.2%
31 Des. 2025		$0.22	$0.26	-14.8%
30 Sep. 2025		$-0.18	$-0.25	26.7%
30 Juni 2025		$-1.26	$-1.05	-20.5%
31 Maret 2025		$2.75	$-0.20	1461.4%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15

Laporan Laba Rugi 15

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$829M	$4M	$241M	$243M	$138M	$88M	$169M	$16M	$31M	$158.3K	$382.0K	$175.0K
R&D Expense	$607M	$506M	$353M	·	·	·	·	·	·	·	$47M	$23M
SG&A Expense	$124M	$99M	$93M	$124M	$81M	$52M	$27M	$19M	$17M	$24M	$8M	$6M
Operating Expenses	$731M	$605M	$446M	$422M	$287M	$181M	$108M	$72M	$68M	$82M	$96M	$53M
Operating Income	$98M	$-601M	$-205M	$-179M	$-149M	$-93M	$61M	$-56M	$-37M	$-82M	$-96M	$-53M
Interest Expense	·	·	$18M	$0	$0	·	·	·	·	·	·	·
Other Non-op	$5M	$-2M	$2M	$765.0K	$2M	$-583.0K	·	$7.5K	$1M	$57.4K	$417.9K	$82.1K
Pretax Income	$52M	$-612M	$-206M	$-173M	$-141M	$-85M	$68M	$-54M	$-34M	$-82M	$-92M	$-59M
Income Tax	$21M	$-3M	$3M	$4M	$2.0K	$2.0K	$174.0K	$2.4K	$2.4K	$2.4K	$2.4K	$5.3K
Net Income	$-2M	$-599M	$-205M	$-176M	$-141M	$-85M	$68M	$-54M	$-34M	$-82M	$-92M	$-59M
EPS (Basic)	$-0.01	$-5.00	$-1.92	$-1.67	$-1.36	$-0.84	$0.72	$-0.65	$-0.47	·	·	·
EPS (Diluted)	$-0.01	$-5.00	$-1.92	$-1.67	$-1.36	$-0.84	$0.69	$-0.65	$-0.47	·	·	·
Shares (Basic)	133,758,000	119,784,000	106,750,000	105,426,000	103,745,000	100,722,000	93,859,000	83,638,469	73,898,598	·	·	·
Shares (Diluted)	133,758,000	119,784,000	106,750,000	105,426,000	103,745,000	100,722,000	98,608,000	83,638,469	73,898,598	·	·	·
EBITDA	$121M	·	$-194M	$-170M	$-142M	$-89M	$64M	$-56M	$-37M	$-82M	$-96M	$-52M

Neraca 27

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	·	·	·	·	$184M	$144M	$222M	$30M	$25M	$85M	$81M	$133M
Short-term Investments	$693M	·	·	$0	$127M	$85M	·	·	·	·	·	$22M
Receivables	$7M	$0	$0	$1M	$10M	$846.0K	$661.4K	$327.4K	$67.8K	$75.0K	·	·
Prepaid Expense	$11M	$10M	$9M	$7M	$4M	$4M	$3M	$1M	$867.4K	$1M	$3M	$588.6K
Other Current Assets	$14M	$5M	$4M	$20M	$2M	$2M	$3M	$640.1K	$1M	$4M	$823.6K	$48.5K
Current Assets	$951M	$695M	$416M	$405M	$385M	$322M	$265M	$79M	$68M	$91M	$103M	$155M
PP&E (Net)	$383M	$386M	$290M	$110M	$49M	$31M	$23M	$14M	$16M	$15M	$5M	$4M
PP&E (Gross)	$463M	$444M	$332M	$142M	$72M	$47M	$35M	$24M	$23M	$20M	$10M	$8M
Accum. Depreciation	$80M	$58M	$42M	$32M	$23M	$16M	$12M	$10M	$7M	$5M	$5M	$4M
Intangibles	$7M	$9M	$10M	$12M	$14M	$15M	$17M	$19M	$20M	$22M	$25M	$1M
Other Non-current Assets	$1M	$4M	$3M	$218.0K	$272.0K	$264.0K	$144.1K	$141.9K	$141.9K	$122.3K	$45.8K	·
Total Assets	$1.39B	$1.14B	$766M	$692M	$710M	$523M	$350M	$112M	$104M	$128M	$132M	$183M
Accounts Payable	$18M	$11M	$36M	$3M	$9M	$7M	$8M	$3M	$4M	$12M	$5M	$3M
Accrued Liabilities	$90M	$63M	$40M	$47M	$14M	$5M	$7M	$5M	$5M	$5M	$5M	$1M
Short-term Debt	·	·	·	·	·	·	·	$223.8K	$208.5K	$194.3K	·	$50.0K
Current Liabilities	$195M	$103M	$105M	$139M	$147M	$41M	$97M	$12M	$19M	$26M	$16M	$12M
Capital Leases	$104M	$111M	$105M	$79M	$23M	$20M	·	·	·	·	$540.8K	$758.3K
Other Non-current Liabilities	·	·	·	$0	·	·	·	$200.0K	$200.0K	$200.0K	$200.0K	$255.2K
Total Debt	·	·	·	·	·	·	·	$223.8K	$208.5K	$194.3K	·	$50.0K
Common Stock	$231.0K	$217.0K	$200.0K	$198.0K	$197.0K	$195.0K	$187.9K	$180.9K	$167.2K	$162.1K	$151.9K	$147.0K
Paid-in Capital	·	·	·	·	·	·	·	$583M	$514M	$494M	$427M	$391M
Retained Earnings	$-1.63B	$-1.63B	$-1.03B	$-821M	$-645M	$-504M	$-419M	$-487M	$-433M	$-398M	$-317M	$-225M
Treasury Stock	$53M	$0	·	·	·	·	·	·	·	·	·	·
AOCI	$6M	$5M	$-3M	$-136.0K	$-69.0K	$18.0K	$-391.6K	$-21.6K	$33.2K	$7.4K	$-136.4K	·
Stockholders' Equity	$466M	$185M	$271M	$399M	$409M	$462M	$244M	$95M	$81M	$96M	$110M	$167M
Liabilities + Equity	$1.39B	$1.14B	$766M	$692M	$710M	$523M	$350M	$112M	$104M	$128M	$132M	$183M
Shares Outstanding	135,702,000	124,376,000	107,312,000	105,960,000	104,327,000	102,376,000	95,506,271	88,505,302	74,785,726	69,746,685	59,544,677	54,656,936

Arus Kas 15

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$22M	$17M	$11M	$9M	$7M	$4M	$3M	$3M	$3M	$3M	$2M	$1M
Stock-based Comp	$63M	$74M	$78M	$121M	$77M	$43M	$12M	$8M	$8M	$12M	$10M	$6M
Deferred Tax	$0	$0	$0	$0	$0	·	·	·	·	·	·	·
Amort. of Intangibles	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$1M	$54.7K
Other Non-cash	$96M	·	$-37M	$-90M	$229M	$-58M	$90M	·	·	·	·	$16M
Operating Cash Flow	$180M	$-463M	$-154M	$-136M	$171M	$-96M	$173M	$-47M	$-24M	$-64M	$-66M	$-35M
CapEx	$23M	$141M	$177M	$53M	$24M	$12M	$12M	$1M	$8M	$4M	$2M	$2M
Investing Cash Flow	$-129M	$-420M	$-96M	$-5M	$-142M	$-241M	$-48M	$-7M	$-49M	$13M	·	·
Stock Issued	$241M	$429M	$0	$0	$0	$250M	$61M	$57M	$12M	$52M	·	$173M
Net Stock Activity	$241M	·	·	$0	·	$250M	$61M	$57M	$12M	$52M	·	·
Financing Cash Flow	$74M	$871M	$253M	$65M	$11M	$258M	$66M	$60M	$12M	$55M	·	·
Net Change in Cash	·	·	·	·	$41M	$-78M	$192M	$5M	$-61M	$4M	$-51M	$113M
Taxes Paid	$814.0K	$-4M	$0	$-2.0K	$-2.0K	$103.0K	$-302.0K	$-2.4K	·	·	·	·
Free Cash Flow	$157M	·	$-331M	$-189M	$148M	$-107M	$161M	$-49M	$-32M	$-68M	$-68M	$-37M
Levered FCF	·	·	$-349M	·	·	·	·	·	·	·	·	·

Profitabilitas 7

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	11.9%	·	-85.2%	-73.4%	-107.8%	-105.9%	36.2%	-346.5%	-117.8%	-51627.1%	-25124.1%	-30443.6%
Net Margin	-0.20%	·	-85.3%	-72.4%	-101.8%	-96.1%	40.3%	-337.3%	·	-51614.6%	-24068.3%	-33503.0%
Pretax Margin	6.2%	·	-85.8%	-71.0%	-101.8%	-96.1%	40.4%	-337.3%	-109.5%	-51613.1%	-24067.7%	-33554.3%
EBITDA Margin	14.5%	·	-80.7%	-69.8%	-103.0%	-101.0%	37.9%	-346.5%	-117.8%	-51627.1%	-25124.1%	-29674.7%
ROA	-0.13%	·	-28.2%	-25.1%	-22.9%	-19.4%	29.5%	-50.5%	·	-62.8%	-58.4%	-53.3%
ROE	-0.50%	·	-61.3%	-45.7%	-33.0%	-17.7%	40.0%	-61.5%	·	-79.4%	-66.5%	-60.4%
ROIC	12.3%	·	-76.6%	-45.8%	-36.5%	-20.2%	24.9%	-58.3%	-45.3%	-85.4%	-87.1%	-32.0%

Likuiditas & Solvabilitas 4

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	4.9	·	4.0	2.9	2.6	7.9	2.7	6.4	3.6	3.5	6.5	13.1
Quick Ratio	0.0	·	0.0	0.0	2.2	5.6	2.3	2.5	1.3	3.3	5.1	13.0
Debt / Equity	·	·	·	·	·	·	·	0.0	0.0	0.0	·	0.0
Interest Coverage	·	·	-11.2	·	·	·	·	·	·	·	·	·

Efisiensi 2

Metrik	Tren	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover		0.7	·	0.3	0.3	0.2	0.2	0.7	0.1	0.3	0.0	0.0	0.0
Receivables Turnover		243.1	·	341.5	41.7	24.9	116.8	341.4	81.7	439.9	2.1	·	·

Per Saham 5

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$3.43	·	$2.53	$3.76	$3.92	$4.51	$2.56	$1.08	$1.09	$1.37	$1.85	$3.05
Revenue / Share	$6.20	·	$2.26	$2.31	$1.33	$0.87	$1.71	·	·	·	·	·
Cash Flow / Share	$1.34	·	$-1.44	$-1.29	$1.65	$-0.95	$1.75	·	·	·	·	·
Cash / Share	·	·	·	·	$1.77	$1.40	$2.32	$0.34	$0.33	$1.22	$1.36	$2.42
EPS (TTM)	$-0.01	$-5.00	$-1.92	$-1.67	$-1.36	$-0.84	$0.69	$-0.65	$-0.47	·	·	·

Tingkat Pertumbuhan 3

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	23258.2%	-98.5%	-1.0%	75.9%	57.2%	·	·	·	·	·	·	·
Revenue CAGR 3Y	50.5%	-70.5%	39.9%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	56.6%	·	·	·	·	·	·	·	·	·	·	·

Valuasi (TTM) 14

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$829M	$4M	$241M	$243M	$138M	$88M	$169M	$16M	$31M	$158.3K	$382.0K	$175.0K
Net Income TTM	$-2M	$-599M	$-205M	$-176M	$-141M	$-85M	$68M	$-54M	$-34M	$-82M	$-92M	$-59M
Market Cap	$4.68B	·	$2.88B	$3.50B	$6.51B	$4.41B	$2.69B	$1.70B	$324M	$513M	$343M	$807M
Enterprise Value	·	·	·	·	·	·	·	$1.67B	$299M	$427M	·	$653M
P/E	-3449.0	-3.9	-14.0	-19.8	-45.9	-51.3	40.8	-29.5	-9.2	·	·	·
P/S	5.6	·	12.0	14.4	47.1	50.1	15.9	105.1	10.3	3237.7	897.8	4613.0
P/B	10.0	·	10.6	8.8	15.9	9.5	11.0	17.7	4.0	5.4	3.1	4.8
P / Tangible Book	10.2	13.6	11.0	9.1	16.5	9.9	·	·	·	·	·	·
P / Cash Flow	26.1	·	-18.7	-25.7	38.0	-46.2	15.6	-35.9	-13.5	-8.0	-5.2	-22.8
P / FCF	29.8	·	-8.7	-18.5	44.1	-41.1	16.7	-34.9	-10.2	-7.5	-5.1	-21.7
EV / EBITDA	·	·	·	·	·	·	·	-29.8	-8.1	-5.2	·	-12.6
EV / FCF	·	·	·	·	·	·	·	-34.3	-9.4	-6.3	·	-17.6
EV / Revenue	·	·	·	·	·	·	·	103.3	9.5	2699.8	·	3732.4
Earnings Yield	-0.03%	-25.8%	-7.1%	-5.1%	-2.2%	-1.9%	2.5%	-3.4%	-10.8%	·	·	·

Laporan Laba Rugi 15

Metrik	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Revenue	$75M	$74M	$264M	$256M	$28M	$543M	$2M	$0	$0	$0	$4M	$16M	$16M	$146M	$63M	$32M
R&D Expense	$198M	$173M	$177M	$175M	$162M	$133M	$137M	·	·	·	·	·	·	·	·	·
SG&A Expense	$47M	$42M	$46M	$38M	$31M	$28M	$27M	$26M	$24M	$25M	$24M	$25M	$24M	$23M	$21M	$32M
Operating Expenses	$245M	$215M	$223M	$212M	$193M	$162M	$164M	$162M	$176M	$126M	$140M	$124M	$119M	$98M	$105M	$115M
Operating Income	$-170M	$-141M	$41M	$44M	$-166M	$381M	$-161M	$-162M	$-176M	$-126M	$-137M	$-108M	$-103M	$48M	$-42M	$-84M
Interest Expense	·	·	·	·	·	·	·	·	·	$7M	$5M	·	$5M	$5M	$3M	·
Other Non-op	$1M	$-2M	$277.0K	$5M	$-176.0K	$438.0K	$341.0K	$-3M	$760.0K	$189.0K	$421.0K	$717.0K	$306.0K	$8.0K	$507.0K	$90.0K
Pretax Income	$-179M	$-138M	$28M	$36M	$-179M	$370M	$-175M	$-173M	$-174M	$-127M	$-139M	$-109M	$-103M	$48M	$-42M	$-82M
Income Tax	$11.0K	$7.0K	$29.0K	$20M	$-437.0K	$2M	$103.0K	$546.0K	$0	$0	$-3M	$2M	$742.0K	$0	$17.0K	$4M
Net Income	$-194M	$-133M	$31M	$-24M	$-175M	$370M	$-173M	$-171M	$-171M	$-125M	$-133M	$-110M	$-103M	$49M	$-41M	$-86M
EPS (Basic)	$-1.36	$-0.93	$0.22	$-0.14	$-1.26	$2.78	$-1.39	$-1.36	$-1.38	$-1.02	$-1.24	$-1.03	$-0.96	$0.46	$-0.39	$-0.81
EPS (Diluted)	$-1.36	$-0.93	$0.22	$-0.11	$-1.26	$2.75	$-1.39	$-1.36	$-1.38	$-1.02	$-1.24	$-1.02	$-0.96	$0.45	$-0.39	$-0.80
Shares (Basic)	143,378,000	142,417,000	137,039,000	·	139,039,000	133,363,000	124,848,000	·	124,199,000	123,285,000	107,415,000	·	107,004,000	106,757,000	106,039,000	·
Shares (Diluted)	143,378,000	142,417,000	140,706,000	·	139,039,000	134,484,000	124,848,000	·	124,199,000	123,285,000	107,415,000	·	107,004,000	108,143,000	106,039,000	·
EBITDA	$-164M	$-135M	$47M	·	$-160M	$387M	$-157M	·	$-172M	$-122M	$-133M	·	$-100M	$50M	$-40M	·

Neraca 24

Metrik	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Cash & Equivalents	·	·	·	·	·	·	·	·	$69M	$128M	$58M	·	$105M	$135M	$202M	·
Short-term Investments	·	$1.60B	$715M	·	·	·	·	·	·	·	·	·	·	·	·	·
Receivables	$9M	$16M	$219M	$7M	$10M	$2M	$2M	$0	·	·	·	·	$1M	$69M	$40M	·
Prepaid Expense	$25M	$22M	$16M	$11M	$24M	$24M	$9M	$10M	$9M	$11M	$11M	·	$10M	$10M	$8M	·
Other Current Assets	$36M	$18M	$23M	$14M	$13M	$12M	$6M	$5M	$4M	$8M	$7M	·	$7M	$14M	$25M	·
Current Assets	$1.67B	$1.84B	$1.17B	$951M	$947M	$1.14B	$571M	$695M	$450M	$542M	$238M	·	$470M	$575M	$575M	·
PP&E (Net)	$373M	$375M	$379M	$383M	$381M	$385M	$387M	$386M	$376M	$359M	$333M	·	$231M	$185M	$147M	·
PP&E (Gross)	$471M	$466M	$465M	$463M	$455M	$453M	$450M	$444M	$430M	$409M	$379M	·	$270M	$221M	$181M	·
Accum. Depreciation	$97M	$91M	$86M	$80M	$74M	$68M	$63M	$58M	$54M	$50M	$46M	·	$39M	$36M	$34M	·
Intangibles	$6M	$6M	$6M	$7M	$7M	$8M	$8M	$9M	$9M	$9M	$10M	·	$11M	$11M	$12M	·
Other Non-current Assets	$6M	$5M	$1M	$1M	$1M	$1M	$3M	$4M	$4M	$210.0K	$232.0K	·	$210.0K	$210.0K	$210.0K	·
Total Assets	$2.11B	$2.27B	$1.60B	$1.39B	$1.38B	$1.57B	$1.01B	$1.14B	$884M	$955M	$626M	·	$796M	$891M	$891M	·
Accounts Payable	$28M	$31M	$33M	$18M	$33M	$10M	$14M	$11M	$27M	$9M	$4M	·	$8M	$10M	$796.0K	·
Accrued Liabilities	$86M	$77M	$130M	$90M	$65M	$78M	$59M	$63M	$48M	$37M	$47M	·	$38M	$40M	$48M	·
Current Liabilities	$283M	$295M	$347M	$195M	$195M	$221M	$94M	$103M	$97M	$65M	$64M	·	$70M	$87M	$122M	·
Capital Leases	$114M	$100M	$102M	$104M	$106M	$108M	$109M	$111M	$112M	$114M	$115M	·	$80M	$80M	$79M	·
Other Non-current Liabilities	·	·	·	·	·	·	·	·	·	·	·	·	$669.0K	·	·	·
Common Stock	$237.0K	$236.0K	$233.0K	$231.0K	$230.0K	$230.0K	$218.0K	$217.0K	$217.0K	$217.0K	$200.0K	·	$199.0K	$199.0K	$199.0K	·
Retained Earnings	$-1.92B	$-1.73B	$-1.60B	$-1.63B	$-1.60B	$-1.43B	$-1.80B	$-1.63B	$-1.45B	$-1.28B	$-1.16B	·	$-916M	$-813M	$-862M	·
Treasury Stock	$53M	$53M	$53M	$53M	·	·	·	$0	·	·	·	·	·	·	·	·
AOCI	$-1M	$742.0K	$7M	$6M	$5M	$4M	$4M	$5M	$-987.0K	$-1M	$-1M	·	$-411.0K	$-332.0K	$-258.0K	·
Stockholders' Equity	$466M	$614M	$568M	$466M	$522M	$683M	$53M	$185M	$331M	$484M	$160M	·	$365M	$447M	$377M	·
Liabilities + Equity	$2.11B	$2.27B	$1.60B	$1.39B	$1.38B	$1.57B	$1.01B	$1.14B	$884M	$955M	$626M	·	$796M	$891M	$891M	·
Shares Outstanding	141,135,000	140,571,000	137,391,000	135,702,000	138,144,000	138,062,000	125,572,000	124,376,000	124,227,000	124,133,000	107,500,000	107,312,000	107,102,000	106,869,000	106,140,000	·

Arus Kas 14

Metrik	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
D&A	$6M	$6M	$6M	$6M	$6M	$6M	$5M	$5M	$4M	$4M	$4M	$3M	$3M	$2M	$2M	$2M
Stock-based Comp	$15M	$17M	$19M	$19M	$13M	$16M	$15M	$19M	$17M	$18M	$20M	$18M	$20M	$21M	$19M	$29M
Amort. of Intangibles	$400.0K	$400.0K	$400.0K	$500.0K	$400.0K	$400.0K	$400.0K	$500.0K	$400.0K	$400.0K	$400.0K	$500.0K	$400.0K	$400.0K	$400.0K	$500.0K
Other Non-cash	·	·	$-43M	·	·	·	$7M	·	·	·	$-8M	·	·	·	$-56M	·
Operating Cash Flow	$-177M	$84M	$13M	$20M	$-155M	$460M	$-146M	$-137M	$-115M	$-92M	$-118M	$-26M	$-21M	$-32M	$-76M	$-69M
CapEx	$4M	$3M	$2M	$7M	$2M	$5M	$8M	$24M	$14M	$34M	$69M	$64M	$47M	$27M	$39M	$33M
Investing Cash Flow	$44M	$-894M	$-24M	$73M	$141M	$-420M	$77M	$-223M	$7M	$-269M	$65M	$31M	$-10M	$-36M	$-81M	$36M
Stock Issued	·	·	$47M	$0	$0	$241M	$0	$0	$0	·	·	$0	$0	·	·	·
Net Stock Activity	·	·	$47M	·	·	·	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$-449.0K	$796M	$-15M	$4M	$-43M	$92M	$21M	$389M	$50M	$431M	$267.0K	$821.0K	$1M	$520.0K	$251M	$855.0K
Net Change in Cash	·	·	·	·	·	·	·	·	·	·	·	·	$-30M	$-67M	$94M	·
Taxes Paid	$22.0K	$12M	$10M	$733.0K	$0	$92.0K	$11.0K	$-7M	$6M	$4M	$-999.0K	$0	$0	$0	$0	$-2.0K
Free Cash Flow	·	·	$11M	·	·	·	$-154M	·	·	·	$-186M	·	·	·	$-114M	·
Levered FCF	·	·	·	·	·	·	·	·	·	·	$-192M	·	·	·	·	·

Profitabilitas 7

Metrik	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Operating Margin	-226.0%	-191.6%	15.5%	·	-596.2%	70.2%	-6456.5%	·	·	·	-3845.2%	·	-649.0%	32.9%	-67.4%	·
Net Margin	-258.2%	-180.0%	11.7%	·	-631.1%	68.3%	-6923.4%	·	·	·	-3741.6%	·	-650.5%	33.3%	-66.1%	·
Pretax Margin	-237.7%	-186.6%	10.7%	·	-645.0%	68.1%	-7004.6%	·	·	·	-3905.6%	·	-653.3%	32.6%	-66.8%	·
EBITDA Margin	-217.8%	-183.6%	17.7%	·	-575.3%	71.3%	-6264.5%	·	·	·	-3738.2%	·	-630.7%	34.4%	-63.7%	·
ROA	-11.1%	-6.9%	2.4%	·	-15.5%	29.3%	-21.1%	·	-20.3%	-13.6%	-17.5%	·	-13.3%	6.1%	-5.4%	·
ROE	-39.3%	-20.5%	9.9%	·	-41.1%	63.5%	-162.5%	·	-49.1%	-26.9%	-49.4%	·	-25.1%	10.8%	-11.0%	·
ROIC	-36.5%	-23.0%	7.2%	·	-31.6%	55.5%	-307.1%	·	-53.3%	-26.1%	-83.1%	·	-28.3%	10.8%	-11.2%	·

Likuiditas & Solvabilitas 3

Metrik	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Current Ratio	5.9	6.2	3.4	·	4.9	5.1	6.1	·	4.7	8.3	3.7	·	6.7	6.6	4.7	·
Quick Ratio	0.0	5.5	2.7	·	0.0	0.0	0.0	·	0.7	2.0	0.9	·	1.5	2.3	2.0	·
Interest Coverage	·	·	·	·	·	·	·	·	·	-17.4	-25.4	·	-19.9	9.5	·	·

Efisiensi 2

Metrik	Tren	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Asset Turnover		0.0	0.0	0.2	·	0.0	0.4	0.0	·	0.0	0.0	0.0	·	0.0	0.2	0.1	·
Receivables Turnover		8.2	8.2	2.4	·	5.1	15.1	0.1	·	·	·	·	·	21.3	4.1	3.1	·

Per Saham 5

Metrik	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Book Value / Share	$3.30	$4.37	$4.14	·	$3.78	$4.95	$0.42	·	$2.66	$3.90	$1.49	·	$3.41	$4.18	$3.55	·
Revenue / Share	$0.52	$0.52	$1.88	·	$0.20	$4.04	$0.02	·	$0.00	$0.00	$0.03	·	$0.15	$1.35	$0.59	·
Cash Flow / Share	·	·	$0.10	·	·	·	$-1.17	·	·	·	$-1.10	·	·	·	$-0.71	·
Cash / Share	·	·	·	·	·	·	·	·	$0.56	$1.03	$0.54	·	$0.98	$1.26	$1.91	·
EPS (TTM)	$-2.18	$-2.08	$1.60	·	$-1.26	$-1.38	$-5.15	·	$-4.66	$-4.24	$-2.77	·	$-1.70	$-1.42	$-1.46	·

Valuasi (TTM) 9

Metrik	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Revenue TTM	$669M	$622M	$1.09B	·	$573M	$545M	$2M	·	$20M	$35M	$182M	·	$256M	$273M	$278M	·
Net Income TTM	$-320M	$-301M	$202M	·	$-148M	$-144M	$-640M	·	$-539M	$-471M	$-297M	·	$-181M	$-150M	$-155M	·
Market Cap	$11.50B	$8.81B	$9.12B	·	$2.18B	$1.76B	$2.36B	·	$3.23B	$3.55B	$3.29B	·	$3.82B	$2.71B	$4.31B	·
P/E	-37.4	-30.1	41.5	·	-12.5	-9.2	-3.7	·	-5.6	-6.7	-11.0	·	-21.0	-17.9	-27.8	·
P/S	17.2	14.2	8.4	·	3.8	3.2	944.3	·	164.3	100.1	18.1	·	14.9	10.0	15.5	·
P/B	24.7	14.4	16.0	·	4.2	2.6	44.9	·	9.8	7.3	20.5	·	10.5	6.1	11.4	·
P / Tangible Book	25.0	14.5	16.2	·	4.2	2.6	53.1	·	10.0	7.5	21.8	·	10.8	6.2	11.8	·
P / Cash Flow	·	·	676.6	·	·	·	-16.1	·	·	·	-27.9	·	·	·	-57.0	·
Earnings Yield	-2.7%	-3.3%	2.4%	·	-8.0%	-10.8%	-27.4%	·	-17.9%	-14.8%	-9.0%	·	-4.8%	-5.6%	-3.6%	·

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16

Metrik	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Pendapatan	$829M	$4M	$241M	$243M	$138M
Margin Operasi %	11.9%	·	-85.2%	-73.4%	-107.8%
Laba Bersih	$-2M	$-599M	$-205M	$-176M	$-141M
EPS Dilusian	$-0.01	$-5.00	$-1.92	$-1.67	$-1.36

Metrik	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Rasio Lancar	4.9	·	4.0	2.9	2.6
Rasio Cepat	0.0	·	0.0	0.0	2.2

Metrik	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Arus Kas Bebas	$157M	·	$-331M	$-189M	$148M

Pemilik institusional (13F) 536 pengaju · $10.7B total · Per tanggal 30 Sep. 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 536

Nilai yang dipegang $10.7B

Posisi baru 124

Posisi yang keluar 54

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya

Posisi baru	Posisi yang keluar	Meningkat	Menurun	Perubahan bersih saham
124 (+4 vs Kuartal sebelumnya)	54 (-2 vs Kuartal sebelumnya)	161 (-7 vs Kuartal sebelumnya)	162 (+41 vs Kuartal sebelumnya)	-134K

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi	Nilai	Saham	% dari 13F yang dilacak	Tipe
BlackRock, Inc.	$1.208.838.379	14.830.553	11,25%	Saham
VANGUARD GROUP INC	$1.015.310.304	15.293.121	9,45%	Saham
Avoro Capital Advisors LLC	$925.591.288	11.355.555	8,61%	Saham
FMR LLC	$655.324.429	8.039.804	6,10%	Saham
VANGUARD PORTFOLIO MANAGEMENT LLC	$517.698.946	6.351.355	4,82%	Saham
VANGUARD CAPITAL MANAGEMENT LLC	$498.103.779	6.110.953	4,63%	Saham
STATE STREET CORP	$464.170.106	5.694.640	4,32%	Saham
NORGES BANK	$317.606.649	3.896.536	2,95%	Saham
Invesco Ltd.	$316.582.884	3.883.976	2,95%	Saham
GEODE CAPITAL MANAGEMENT, LLC	$298.813.042	3.530.612	2,78%	Saham
FRED ALGER MANAGEMENT, LLC	$269.139.418	3.301.919	2,50%	Saham
BAKER BROS. ADVISORS LP	$162.431.742	1.992.783	1,51%	Saham
Siren, L.L.C.	$139.828.449	1.715.476	1,30%	Saham
Vestal Point Capital, LP	$128.378.250	1.575.000	1,19%	Saham
DEERFIELD MANAGEMENT COMPANY, L.P.	$113.221.873	1.389.055	1,05%	Saham
FIRST TRUST ADVISORS LP	$110.276.346	1.352.918	1,03%	Saham
Driehaus Capital Management LLC	$110.083.820	1.350.556	1,02%	Saham
NORTHERN TRUST CORP	$97.230.671	1.192.868	0,90%	Saham
DIMENSIONAL FUND ADVISORS LP	$96.310.585	1.181.608	0,90%	Saham
GOLDMAN SACHS GROUP INC	$93.737.071	1.150.007	0,87%	Saham
BANK OF AMERICA CORP /DE/	$92.905.915	1.139.810	0,86%	Saham
Hood River Capital Management LLC	$91.352.088	1.120.747	0,85%	Saham
Holocene Advisors, LP	$90.164.487	1.106.177	0,84%	Saham
JANUS HENDERSON GROUP PLC	$90.119.095	1.436.990	0,84%	Saham
MORGAN STANLEY	$88.425.108	1.084.835	0,82%	Saham
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	$83.453.449	1.330.996	0,78%	Saham
Fisher Asset Management, LLC	$78.061.392	957.691	0,73%	Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$75.309.290	923.927	0,70%	Saham
VANGUARD FIDUCIARY TRUST CO	$73.093.114	896.738	0,68%	Saham
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$70.718.076	867.600	0,66%	Opsi beli
UBS Group AG	$70.222.495	861.520	0,65%	Saham
Bank of New York Mellon Corp	$70.060.927	859.538	0,65%	Saham
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC	$67.673.433	830.247	0,63%	Saham
Western Financial Corp/CA	$66.857.681	820.239	0,62%	Saham
JPMORGAN CHASE & CO	$51.770.437	637.399	0,48%	Saham
Connor, Clark & Lunn Investment Management Ltd.	$50.990.129	625.569	0,47%	Saham
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$48.626.665	596.573	0,45%	Saham
TWO SIGMA INVESTMENTS, LP	$47.325.440	580.609	0,44%	Saham
Pictet Asset Management Holding SA	$46.708.118	573.419	0,43%	Saham
BNP PARIBAS FINANCIAL MARKETS	$45.534.991	558.643	0,42%	Saham
1832 Asset Management L.P.	$43.893.135	538.500	0,41%	Saham
PRINCIPAL FINANCIAL GROUP INC	$41.949.773	514.658	0,39%	Saham
VOYA INVESTMENT MANAGEMENT LLC	$39.409.678	483.495	0,37%	Saham
Balyasny Asset Management L.P.	$38.370.343	470.744	0,36%	Saham
RENAISSANCE TECHNOLOGIES LLC	$38.221.751	468.921	0,36%	Saham
FRANKLIN RESOURCES INC	$37.668.462	462.133	0,35%	Saham
D. E. Shaw & Co., Inc.	$35.176.456	431.560	0,33%	Saham
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$34.600.995	424.500	0,32%	Opsi jual
Nuveen, LLC	$33.898.624	415.883	0,32%	Saham
RHUMBLINE ADVISERS	$30.557.778	374.897	0,28%	Saham

Tampilkan semua 536 pemilik institusional →

Aktivis & pemilik 5%+ 3 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju	Diajukan	Kepemilikan	Status	Tujuan	Pengajuan
Sarepta Therapeutics, Inc., Sarepta Therapeutics Investments, Inc. ×2 pengajuan	15 Agu 2025	0,00%	Amandemen	·	SEC
Silence Therapeutics Plc ×3 pengajuan	8 Des. 2017	·	Pengajuan awal	·	SEC
Novartis Institutes for BioMedical Research, Inc., Novartis AG ×2 pengajuan	28 Nov. 2017	·	Pengajuan awal	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 33 orang dalam · 17 pejabat · 16 direktur

19

Orang Dalam	Peran	Aktivitas terakhir	Saham dimiliki	Jual 12m	Bersih 12m
Christopher Richard Anzalone	Chief Executive Officer	2 Jan. 2026 S	3.792.739	25	$-24.010.562
Daniel Joseph Apel	Chief Financial Officer	22 April 2026 S	162.905	3	$-934.286
Kenneth Allen Myszkowski	Chief Financial Officer	7 Jan. 2025 S	455.433	0	$0
McDonnel Paul Clayton	CFO (former)	17 Juli 2009 J	·	0	$0
Joseph Theodore Kingsley III	Chief Financial Officer	29 Maret 2007 A	12.000	0	$0
Leon Ekchian	President	14 Nov. 2005 A	·	0	$0
Patrick O'Brien	COO	6 Jan. 2026 A	547.408	12	$-3.123.349
Bruce D Given	Chief Operating Officer	28 April 2020 M	850.730	0	$0
James C Hamilton	Chief Medical Officer	23 April 2026 S	226.958	10	$-4.626.561
Tracie Oliver	Chief Commercial Officer	2 Juli 2024 S	127.107	0	$0
Javier San Martin	Chief Medical Officer	5 Jan. 2024 S	198.497	0	$0
Curt Bradshaw	Chief Scientific Officer	20 Nov. 2020 S	0	0	$0
Zhen Li	Snr. VP, Chem and Non-Clin Dev	14 Jan. 2019 S	201.700	0	$0
Peter Brian Leone	VP, Strategic Bus. Initiatives	19 Okt. 2018 M	130.000	0	$0
David L. Lewis	Chief Scientific Officer	1 Jan. 2016 A	0	0	$0
STEWART R BRUCE	Executive Chairman	4 Maret 2010 A	711.500	0	$0
James M Phillips JR	Secretary	31 Maret 2004 A	·	0	$0
Michael S Perry	Direktur	18 Agu 2026 S	111.459	2	$-2.004.418
Adeoye Y Olukotun	Direktur	18 Agu 2026 S	31.600	4	$-850.543
Matthew Gregory Cohen	Direktur	15 Juni 2026 A	11.882	0	$0
Hongbo Lu	Direktur	12 Mei 2026 S	52.012	1	$-228.334
Mauro Ferrari	Direktur	26 Des. 2025 S	69.053	2	$-1.020.512
Victoria Vakiener	Direktur	19 Des. 2025 S	35.723	3	$-679.491
William D. Waddill	Direktur	19 Des. 2025 S	56.563	3	$-566.039
Douglas S Ingram	Direktur	16 Des. 2025 A	46.215	0	$0
Douglas B Given	Direktur	17 Des. 2024 S	124.167	0	$0
Marianne De Backer	Direktur	10 Jan. 2023 A	31.267	0	$0
Edward W Frykman	Direktur	1 Jan. 2018 A	148.852	0	$0
Charles Mckenney	Direktur	4 Maret 2015 A	42.220	0	$0
Leroy T Rahn	Direktur	4 Maret 2010 A	·	0	$0
David M Knott	Pemilik 10%	21 Maret 2007 S	742.600	0	$0
Marshall Robert Ching	Pemilik 10%	23 Juni 2005 U	28.666	0	$0
James Hassard	·	22 Juni 2021 S	105.750	0	$0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 77 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana	Bobot	Unit	Per tanggal	Sumber
ADPV · Series Portfolios Trust	4,99%	105.093 NS	31 Juli 2026	N-PORT
IBRN · iShares Trust	4,45%	4.021 SH	11 Sep. 2026	Harian
HTEC · EXCHANGE TRADED CONCEPTS TRUST	2,08%	16.973 NS	31 Juli 2026	N-PORT
RFG · Invesco Exchange-Traded Fund Trust	1,94%	98.200 SH	1 Okt. 2026	Harian
FXH · First Trust Exchange-Traded AlphaDE…	1,76%	217.383 NS	31 Juli 2026	N-PORT
XMMO · Invesco Exchange-Traded Fund Trust	1,68%	1.799.303 SH	1 Okt. 2026	Harian
BBP · ETFis Series Trust I	1,56%	18.212 NS	31 Juli 2026	N-PORT
PTH · Invesco Exchange-Traded Fund Trust	1,49%	83.440 SH	1 Okt. 2026	Harian
PAMC · Pacer Funds Trust	1,03%	6.557 NS	31 Juli 2026	N-PORT
PDP · Invesco Exchange-Traded Fund Trust	1,03%	232.243 SH	1 Okt. 2026	Harian
LABU · Direxion Shares ETF Trust	0,82%	47.707 NS	31 Juli 2026	N-PORT
IBB · iShares Trust	0,81%	1.011.317 SH	11 Sep. 2026	Harian
JSMD · Janus Detroit Street Trust	0,80%	99.071 NS	31 Juli 2026	N-PORT
FNY · First Trust Exchange-Traded AlphaDE…	0,66%	45.043 NS	31 Juli 2026	N-PORT
FDMO · FIDELITY COVINGTON TRUST	0,62%	66.366 NS	31 Juli 2026	N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust …	0,61%	10.003 SH	1 Okt. 2026	Harian
IVOG · VANGUARD ADMIRAL FUNDS	0,60%	138.986 SH	19 Agu 2026	Harian
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,41%	33.395 NS	31 Juli 2026	N-PORT
IQSM · New York Life Investments ETF Trust	0,39%	15.107 NS	31 Juli 2026	N-PORT
PTMC · Pacer Funds Trust	0,34%	15.508 NS	31 Juli 2026	N-PORT
FNX · First Trust Exchange-Traded AlphaDE…	0,31%	50.547 NS	31 Juli 2026	N-PORT
IVOO · VANGUARD ADMIRAL FUNDS	0,31%	227.611 SH	19 Agu 2026	Harian
QVMM · Invesco Exchange-Traded Fund Trust …	0,30%	18.702 SH	1 Okt. 2026	Harian
VBK · VANGUARD INDEX FUNDS	0,30%	1.772.235 SH	19 Agu 2026	Harian
VFMO · VANGUARD WELLINGTON FUND	0,27%	67.223 SH	19 Agu 2026	Harian
BKMC · BNY Mellon ETF Trust	0,26%	19.553 NS	31 Juli 2026	N-PORT
MIDU · Direxion Shares ETF Trust	0,26%	2.069 NS	31 Juli 2026	N-PORT
FSMD · FIDELITY COVINGTON TRUST	0,25%	72.735 NS	31 Juli 2026	N-PORT
PWS · Pacer Funds Trust	0,23%	652 NS	31 Juli 2026	N-PORT
ISCG · iShares Trust	0,21%	24.642 SH	11 Sep. 2026	Harian
JMOM · J.P. Morgan Exchange-Traded Fund Tr…	0,21%	61.794 NS	31 Juli 2026	N-PORT
IWP · iShares Trust	0,21%	478.561 SH	11 Sep. 2026	Harian
FAD · First Trust Exchange-Traded AlphaDE…	0,20%	13.526 NS	31 Juli 2026	N-PORT
IYH · iShares Trust	0,18%	78.886 SH	11 Sep. 2026	Harian
FTLS · First Trust Exchange-Traded Fund III	0,17%	49.621 NS	31 Juli 2026	N-PORT
SMMD · iShares Trust	0,16%	72.102 SH	11 Sep. 2026	Harian
ESML · iShares Trust	0,15%	51.818 SH	11 Sep. 2026	Harian
FHLC · FIDELITY COVINGTON TRUST	0,15%	56.561 NS	31 Juli 2026	N-PORT
VHT · VANGUARD WORLD FUND	0,14%	357.682 SH	19 Agu 2026	Harian
VXF · VANGUARD INDEX FUNDS	0,13%	1.615.938 SH	19 Agu 2026	Harian
VB · VANGUARD INDEX FUNDS	0,13%	3.068.726 SH	19 Agu 2026	Harian
PRFZ · Invesco Exchange-Traded Fund Trust	0,10%	42.814 SH	1 Okt. 2026	Harian
DFAS · Dimensional ETF Trust	0,10%	175.306 NS	31 Juli 2026	N-PORT
TILT · FlexShares Trust	0,09%	24.490 NS	31 Juli 2026	N-PORT
WSML · iShares Trust	0,09%	7.591 SH	11 Sep. 2026	Harian
IWR · iShares Trust	0,08%	552.714 SH	11 Sep. 2026	Harian
EQAL · Invesco Exchange-Traded Fund Trust …	0,08%	9.118 SH	1 Okt. 2026	Harian
LRND · New York Life Investments ETF Trust	0,07%	3.180 NS	31 Juli 2026	N-PORT
IWS · iShares Trust	0,04%	74.359 SH	11 Sep. 2026	Harian
SMDX · Tidal Trust III	0,04%	602 NS	31 Juli 2026	N-PORT
IUSG · iShares Trust	0,03%	123.000 SH	11 Sep. 2026	Harian
DFAC · Dimensional ETF Trust	0,03%	153.604 NS	31 Juli 2026	N-PORT
RWK · Invesco Exchange-Traded Fund Trust …	0,02%	4.240 SH	30 Sep. 2026	Harian
IWF · iShares Trust	0,02%	319.335 SH	11 Sep. 2026	Harian
VONE · VANGUARD SCOTTSDALE FUNDS	0,02%	22.223 SH	19 Agu 2026	Harian
VONG · VANGUARD SCOTTSDALE FUNDS	0,02%	133.946 SH	19 Agu 2026	Harian
VTHR · VANGUARD SCOTTSDALE FUNDS	0,02%	11.327 SH	19 Agu 2026	Harian
ESGV · VANGUARD WORLD FUND	0,02%	30.534 SH	19 Agu 2026	Harian
DFAU · Dimensional ETF Trust	0,02%	25.782 NS	31 Juli 2026	N-PORT
RECS · Columbia ETF Trust I	0,02%	11.168 NS	31 Juli 2026	N-PORT
ITOT · iShares Trust	0,02%	185.916 SH	11 Sep. 2026	Harian
IWB · iShares Trust	0,02%	93.225 SH	11 Sep. 2026	Harian
IWV · iShares Trust	0,01%	36.139 SH	11 Sep. 2026	Harian
DCOR · Dimensional ETF Trust	0,01%	5.886 NS	31 Juli 2026	N-PORT
DFSU · Dimensional ETF Trust	0,01%	3.408 NS	31 Juli 2026	N-PORT
IWD · iShares Trust	0,01%	111.121 SH	11 Sep. 2026	Harian
REVS · Columbia ETF Trust I	0,01%	439 NS	31 Juli 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,01%	4.247.432 SH	19 Agu 2026	Harian
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0,01%	111.719 SH	19 Agu 2026	Harian
VONV · VANGUARD SCOTTSDALE FUNDS	0,01%	30.273 SH	19 Agu 2026	Harian
DFUS · Dimensional ETF Trust	0,01%	24.661 NS	31 Juli 2026	N-PORT
IJH · iShares Trust	·	4.942.845 SH	11 Sep. 2026	Harian
IJK · iShares Trust	·	816.879 SH	11 Sep. 2026	Harian
XJH · iShares Trust	·	19.242 SH	8 Sep. 2026	Harian
ISCB · iShares Trust	·	5.539 SH	11 Sep. 2026	Harian
ISCV · iShares Trust	·	10.026 SH	11 Sep. 2026	Harian
SMLF · iShares Trust	·	45.534 SH	11 Sep. 2026	Harian

ARWR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21

peringkat · 20 analis BELI

Target median $104.00 +62,0%

6 30,0% Beli Kuat

13 65,0% Beli

1 5,0% Tahan

0 0,0% Jual

0 0,0% Jual Kuat

Target Harga 12 Bulan

13 analis · 2026-09-28

Target rata-rata $107.23 +67,1%

← Di bawah semua target Harga saat ini $64.19

Rendah$74.00 Rata-rata$107.23 Tinggi$126.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
ARWR	$4.68B	-3449.0	23258.2%	-0.20%	-0.50%	·
KRYS	$7.20B	36.0	33.9%	52.6%	18.1%	·
KYMR	$6.33B	-21.1	-16.7%	-794.0%	-24.4%	·
CYTK	$7.81B	-9.7	376.6%	-891.6%	152.7%	·
PTGX	$5.47B	-42.6	-89.4%	-282.8%	-20.3%	·
PCVX	$6.05B	-8.2	·	·	-26.6%	·
TGTX	$4.63B	10.8	87.3%	72.6%	96.7%	·
CAI	$7.62B	-8.4	97.0%	-8.4%	-13.2%	·

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

23

Arrowhead Pharmaceuticals Inc. (ARWR): Miliarder Ken Fisher Bertaruh Besar pada Pharma Yahoo Finance · 6 bulan, 2 minggu lalu

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock

ARWR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

ARWR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Tentang Arrowhead Pharmaceuticals, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Pemilik institusional (13F) 536 pengaju · $10.7B total · Per tanggal 30 Sep. 2026

Aktivis & pemilik 5%+ 3 saham

Orang dalam perusahaan 33 orang dalam · 17 pejabat · 16 direktur

Kepemilikan ETF Dimiliki oleh 77 ETF

ARWR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

Target Harga 12 Bulan

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap